My father, Len Malaghan, was diagnosed with Hodgkin’s disease in 1962. Len’s treatment exposed him to the benefits of new drugs as well as the dedication and commitment of the cancer specialists. This experience was formative in demonstrating the benefits of undertaking research in New Zealand, and Len decided to make a difference. Keep Reading